Abiopharma

Silo Pharma Notification (SILO)

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

Aditxt Unveils bitXbio™: A Bitcoin-Backed Treasury Strategy Designed to Accelerate Biotech Commercialization

New Form 8-K - COLLEGIUM PHARMACEUTICAL, INC Filed: 2025-07-07 AccNo: 0001104659-25-065981 Size: 186 KB Item 8.01: Other Events

New Form 8-K - Denali Therapeutics Inc. Filed: 2025-07-07 AccNo: 0001714899-25-000146 Size: 191 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Bausch Health Notification

Inspire Medical Systems, Inc. - Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025

Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)

Ainos and Solomon Partner to Bring SmellTech Across Asias Industrial Landscape

GE HealthCare to announce second quarter 2025 results on July 30, 2025

New Form 8-K - Pacira BioSciences, Inc. Filed: 2025-07-07 AccNo: 0001104659-25-065979 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item …

Collegium Announces $150 Million Share Repurchase Program

Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format

Astria Therapeutics to Present at Upcoming 2025 US Hereditary Angioedema Association National Summit